Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target …
K Ikawa, A Nakashima, N Morikawa… - Antimicrobial agents …, 2011 - Am Soc Microbiol
The present study investigated the pharmacokinetics of meropenem and biapenem in bile
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
[引用][C] Clinical Pharmacokinetics of Meropenem and Biapenem in Bile and Dosing Considerations for Biliary Tract Infections Based on Site-Specific Pharmacodynamic …
K IKAWA, A NAKASHIMA… - Antimicrobial …, 2011 - pascal-francis.inist.fr
Clinical Pharmacokinetics of Meropenem and Biapenem in Bile and Dosing Considerations
for Biliary Tract Infections Based on Site-Specific Pharmacodynamic Target Attainment …
for Biliary Tract Infections Based on Site-Specific Pharmacodynamic Target Attainment …
Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target …
K Ikawa, A Nakashima, N Morikawa… - Antimicrobial …, 2011 - pubmed.ncbi.nlm.nih.gov
The present study investigated the pharmacokinetics of meropenem and biapenem in bile
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
[PDF][PDF] Clinical Pharmacokinetics of Meropenem and Biapenem in Bile and Dosing Considerations for Biliary Tract Infections Based on Site-Specific Pharmacodynamic …
K Ikawa, A Nakashima, N Morikawa, K Ikeda… - ANTIMICROBIAL …, 2011 - Citeseer
MATERIALS AND METHODS Study design and subject population. This study was a
prospective and openlabel study of meropenem and biapenem conducted at Hiroshima …
prospective and openlabel study of meropenem and biapenem conducted at Hiroshima …
Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target …
K Ikawa, A Nakashima, N Morikawa, K Ikeda… - 2011 - cabidigitallibrary.org
The present study investigated the pharmacokinetics of meropenem and biapenem in bile
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target …
K Ikawa, A Nakashima, N Morikawa… - Antimicrobial Agents …, 2011 - europepmc.org
The present study investigated the pharmacokinetics of meropenem and biapenem in bile
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
[HTML][HTML] Clinical Pharmacokinetics of Meropenem and Biapenem in Bile and Dosing Considerations for Biliary Tract Infections Based on Site-Specific …
K Ikawa, A Nakashima, N Morikawa… - Antimicrobial Agents …, 2011 - ncbi.nlm.nih.gov
The present study investigated the pharmacokinetics of meropenem and biapenem in bile
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
and estimated their pharmacodynamic target attainment at the site. Meropenem (0.5 g) or …
[PDF][PDF] Clinical Pharmacokinetics of Meropenem and Biapenem in Bile and Dosing Considerations for Biliary Tract Infections Based on Site-Specific Pharmacodynamic …
K Ikawa, A Nakashima, N Morikawa… - ANTIMICROBIAL …, 2011 - researchgate.net
MATERIALS AND METHODS Study design and subject population. This study was a
prospective and openlabel study of meropenem and biapenem conducted at Hiroshima …
prospective and openlabel study of meropenem and biapenem conducted at Hiroshima …
Clinical Pharmacokinetics of Meropenem and Biapenem in Bile and Dosing Considerations for Biliary Tract Infections Based on Site-Specific Pharmacodynamic …
K Ikawa, A Nakashima, N Morikawa, K Ikeda… - Antimicrobial Agents …, 2011 - cir.nii.ac.jp
抄録< jats: title> ABSTRACT</jats: title>< jats: p> The present study investigated the
pharmacokinetics of meropenem and biapenem in bile and estimated their …
pharmacokinetics of meropenem and biapenem in bile and estimated their …
[引用][C] Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic …
K IKAWA - Antimicrob Agents Chemother, 2011 - cir.nii.ac.jp
Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for
biliary tract infections based on site-specific pharmacodynamic target attainment | CiNii …
biliary tract infections based on site-specific pharmacodynamic target attainment | CiNii …